Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of sitagliptin during metformin up-titration vs metformin up-titration alone in type 2 diabetes mellitus
2015-004224-59Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Metformin up-titration + sitagliptin with Metformin up-titration + placebo (2 arms). Primary endpoint: Change in HbA1c from baseline at Week 20. Started Apr 2016; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-004224-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004224-59.